Biotech Pharma Named a Municipal Model of Integrity-BIOTECH PHARMACEUTICAL CO., LTD_EGF Vaccine

Home
About Us
About Us

BPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
S&T
S&T

International-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
- Research Areas
- Technology Platforms
Research and Development
Research and Development

China has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
Blog
Blog

Integrating industry-related media coverage as well as the company’s various activities and updates.
- Company News
- Media Reports
Join Us
Join Us

Boasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
- Post-Doctoral Center
Contact Us
Contact Us

ThaiXinLife Consultation Hotline: +86 4006592330
Company Main Line: +86-10-51571020
- Contact Us

中

Company News

Media News

Biotech Pharma Named a Municipal Model of Integrity

Category:

Blog

Company News

Author:

Source:

Release date:

2023-05-30

To actively foster and practice the core socialist values, fully showcase the capital's achievements in building trustworthiness, and inspire all sectors to comprehensively implement tasks related to the social credit system, thereby proactively shaping a trustworthy and civilized Beijing, the Office of the Capital Spiritual Civilization Construction Committee, the Beijing Municipal Bureau of Economy and Information Technology, the Beijing Municipal Administration for Market Regulation, the Beijing Municipal Bureau of Commerce, the Beijing Municipal Bureau of Culture and Tourism, the Beijing Municipal Bureau of Statistics, the Beijing Taxation Bureau of the State Administration of Taxation, and the Beijing Federation of Industry and Commerce have jointly launched the city-wide "Hundreds of Industries, Ten Thousand Enterprises" campaign to build trust and civility in Beijing. BIOTECH PHARMACEUTICAL CO., LTD has enthusiastically responded and actively participated in this initiative.

Following the principles of strictness, pragmatism, emphasis on quality, and effectiveness, the process involved enterprise applications, industry (district) recommendations, eligibility verification, credit reviews, expert evaluations, departmental approvals, and public announcements. On May 23, 2023, the Office of the Capital Civilization Development Committee announced the list of "Beijing Integrity-Cultivating Enterprises" for 2022, and Biotech Pharma was one of the 11 companies from Beijing Economic-Technological Development Area to make the cut.

Biotech Pharma will collaborate with relevant departments, cherish this honor, and continuously enhance its integrity system. We will actively serve as a model and leader, contributing further to the high-quality development of the capital in the new era.